Is junopharm.ca Safe? Security Analysis for Juno Pharmaceuticals Corp.
https://junopharm.caCheck if junopharm.ca is a scam or legitimate. Free security scan and reviews.
Below Healthcare avg (65)
10,000+
Domains scanned
500+
Security teams trust us
EveryPay
Secure checkout
Instant
Reports delivered
Get the professional PDF report for junopharm.ca
Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
AI Summary
Juno Pharmaceuticals Corp. operates in the healthcare sector, specializing in licensing and acquiring specialized pharmaceutical products with limited competition and high market entry barriers. The company recently merged with Omega Laboratories Limited to form Juno Pharma Canada Inc, headquartered in Montreal, Quebec. The website serves as a corporate presence to inform stakeholders about the business and directs users to a new website for further engagement. Technically, the site is built on a modern CMS platform (Multiscreensite) and employs contemporary web technologies including service workers for PWA capabilities, Google Analytics, and Snowplow for analytics. However, it lacks visible privacy and cookie policies, and no contact information is provided on the homepage, which impacts user trust and compliance. Security posture is moderate with HTTPS enforced and captcha protections, but missing security headers and vulnerability disclosures reduce overall security maturity. The absence of WHOIS data raises concerns about domain legitimacy, although the website content appears professional and business-focused.
Detected Technologies
11 urgent findings need attention
1 critical · 10 high
- + 3 more findings in the full report below
Keep junopharm.ca under constant watch
Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.
Security drift alerts
Risk score drops, new high-severity issues, and header hardening gaps
Compliance watch
GDPR / NIS2 posture changes with governance evidence snapshots
Infrastructure surface
Unexpected open services, SSL expiry, DNS & email authentication changes
Content & tracker intelligence
Marketing tech shifts, analytics drift, and AI recommendation updates
Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.
Security Headers
4 findings
70/100
GDPR Compliance
4 findings
35/100
NIS2 Compliance
9 findings
2/100
Email Security
5 findings
60/100
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
Juno Pharmaceuticals holds a niche position in the pharmaceutical licensing and acquisition market in Canada, targeting healthcare professionals and industry stakeholders. The business model focuses on acquiring specialized products with inherent market barriers, suggesting a strategy to maintain competitive advantage through exclusivity. The recent merger indicates growth and consolidation. The website acts primarily as a corporate informational portal with limited direct customer interaction. The lack of detailed contact information and policies suggests a low emphasis on direct consumer engagement or e-commerce. The presence of a related domain (junopharma.com) indicates a transition or expansion of their digital footprint. Overall, the company appears to be a small-sized entity with focused operations in healthcare licensing.
Extracted Contact Information
Marketing Intelligence Data
Physical Addresses (1)
Security Posture Analysis
Comprehensive Security Assessment
The website demonstrates a basic to moderate security posture. HTTPS is properly implemented, and service workers are registered to enhance performance and offline capabilities. The use of Google reCAPTCHA and Friendly Captcha indicates attention to bot mitigation on forms, although no forms are present on the homepage. The absence of explicit security headers such as Content-Security-Policy, X-Frame-Options, and others is a notable gap. No vulnerability disclosures or incident response contacts are provided, limiting transparency and readiness for security incidents. The missing WHOIS data is a significant concern for domain legitimacy and trust. Overall, while the site is not evidently vulnerable, there are areas for improvement in security best practices and compliance documentation.
Strategic Recommendations
Priority Actions for Security Improvement
Publish comprehensive privacy and cookie policies to improve compliance and user trust.
✨Observations
AI-powered comprehensive website and business analysis.
AI-Enhanced Website Analysis
Business Insights
Juno Pharmaceuticals Corp.
Juno licenses and acquires specialized pharmaceutical products that have limited competitors and inherent barriers to market entry.
good
consistent
Technical Stack
moderate
good
basic
good
Security Assessment
- HTTPS enforced
- Service Worker registered
- Use of reCAPTCHA and Friendly Captcha for forms
Analytics & Tracking
Advertising & Marketing
Website Quality Assessment
Key Observations
Website is accessible and not blocked by WAF or security mechanisms.
Get this report delivered to your inbox
Receive a summary of the junopharm.ca security findings by email. Quick and easy to share with decision makers.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Missing X-XSS-Protection header
MEDIUMLegacy XSS protection (deprecated but still recommended)
Missing Referrer-Policy header
LOWControls referrer information sent with requests
Missing Permissions-Policy header
MEDIUMControls browser features and APIs
Sensitive data may be cached
LOWCache-Control header should include "no-store" for sensitive pages
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
No Privacy Policy found
HIGHGDPR requires a clear and accessible privacy policy
No Cookie Policy found
HIGHGDPR requires clear information about cookie usage
No Cookie Consent Banner found
HIGHGDPR requires explicit consent for non-essential cookies
Third-party services without privacy policy
HIGHDetected services: Google Analytics
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No vulnerability reporting mechanism
MEDIUMClear vulnerability reporting supports coordinated disclosure
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Critical sector without clear security compliance
HIGHDetected sectors: energy, transport, health, digital
Need this report as a PDF?
Download the complete junopharm.ca security analysis as a professional PDF. Share it with your team, clients, or stakeholders.
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
No DKIM record found
MEDIUMDKIM adds cryptographic signatures to emails
No BIMI Record
LOWBIMI displays brand logos in email clients
No MTA-STS Policy
MEDIUMMTA-STS enforces TLS for email delivery
No TLS-RPT Record
LOWTLS-RPT provides reporting for email TLS issues
No email authentication configured
CRITICALDomain is vulnerable to email spoofing
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
Weak Protocols Supported
HIGHServer supports weak protocols: TLSv1.1
OCSP Stapling Not Enabled
LOWOCSP stapling improves performance and privacy
Certificate Transparency Not Implemented
LOWCertificate is not logged in Certificate Transparency logs
SSL Certificate Expires Within 90 Days
MEDIUMSSL certificate expires in 50 days
Partial SSL/TLS Assessment
LOWCompleted 3 of 4 security checks due to time constraints
Protocol Support
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
CAA Records Not Configured
LOWCertificate Authority Authorization (CAA) records not found
No DMARC Record
MEDIUMDMARC policy not configured
Domain Registration Details
- •Privacy/proxy registration detected
DNS Records
DNSSEC Status
DNS Performance
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
Good Network Security Posture
LOWNo unnecessary services detected on common risky ports
How does junopharm.ca compare?
See how junopharm.ca stacks up against similar websites in the same industry.
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings
Additional Findings
Download the junopharm.ca report as PDF
Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
Scan your own website
Liked the junopharm.ca report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.
Or browse our directory of >10,000 scanned websites.
How did we do?
Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.
What others say about junopharm.ca
Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.
Community rating
—out of 5
0 reviews published